Xin'ao (Osimertinib) 40mg/80mg*30 | Hansoh China Generic | GLT

Generic Information: Xin'ao (Osimertinib) 40mg / 80mg — China-Mainland

Xin'ao is a China-made generic of osimertinib produced by Jiangsu Hansoh Pharmaceutical Group Co., Ltd., one of China's leading oncology-focused manufacturers. It is supplied in two strengths — 40 mg and 80 mg — each in 30-tablet packs. The 80 mg strength is the standard once-daily dose, while the 40 mg strength is used for dose reduction to manage side effects, matching the originator's dosing structure. Hansoh's osimertinib generic has passed China's generic-drug quality and efficacy consistency evaluation, and it is reimbursed under the national medical insurance scheme.

For buyers, Xin'ao represents a Chinese generic whose manufacturer is well established and whose product is regulatory-reviewed for bioequivalence to the originator. Both the 40 mg and 80 mg strengths carry the same active ingredient.

What Is Xin'ao Used For?

Xin'ao is indicated for EGFR mutation-positive non-small cell lung cancer, including first-line advanced disease, T790M-positive disease after resistance to a prior EGFR TKI, and adjuvant therapy after surgery in eligible EGFR-mutant patients. Its central nervous system penetration supports use in brain-metastatic disease.

How Does Xin'ao Work?

The osimertinib in Xin'ao is an irreversible mutant-selective EGFR inhibitor that blocks EGFR with exon 19 deletions, L858R mutations and the T790M mutation while sparing wild-type EGFR. This mechanism accounts for its efficacy across treatment lines and its comparatively manageable side-effect profile.

Indications

• First-line advanced EGFR-mutant NSCLC.
• Adjuvant therapy after resection of EGFR-mutant NSCLC.
• T790M-positive NSCLC after prior EGFR-TKI therapy.

Dosage and Administration

The standard dose is 80 mg once daily; the 40 mg strength is used when a dose reduction is needed for toxicity. Take the tablet whole with water, with or without food. Missed doses beyond 12 hours are skipped. Treatment continues until disease progression or unacceptable side effects.

Side Effects

Common side effects include diarrhoea, rash, dry skin, nail changes, stomatitis and fatigue. Interstitial lung disease, QT prolongation and cardiomyopathy are rare but serious; patients should report new respiratory symptoms or palpitations and receive routine monitoring.

Storage

Store Xin'ao below 30°C, in the original package, in a dry place, out of children's reach. Use before the expiry date.

Why Choose the China Version of Xin'ao?

Xin'ao benefits from China's competitive generic-drug pricing and national reimbursement, which makes it one of the most economical ways to access osimertinib — typically a small fraction of the branded originator's Western list price, and even lower than the reimbursed originator price within China. Because Hansoh's product has passed bioequivalence review, patients gain a regulatory-assured, lower-cost option. GLT documents each batch and supports buyers through import requirements.

How to Order Xin'ao from GLT

To order Xin'ao 40 mg or 80 mg (30 tablets), message GLT on WhatsApp at +86 15234153837 or email [email protected]. Specify the strength, quantity, destination and order type, and we will confirm availability, batch details and export documentation.

FAQ

What strengths does Xin'ao come in? Xin'ao is available in 40 mg and 80 mg strengths, each in 30-tablet packs.

Who makes Xin'ao? Xin'ao is manufactured by Jiangsu Hansoh Pharmaceutical Group Co., Ltd. in China.

Is Xin'ao reimbursed in China? Yes, Hansoh's osimertinib generic has passed consistency evaluation and is reimbursed under China's national medical insurance scheme.